PND57 TEMPORAL TRENDS AND GEOGRAPHIC DISCREPANCIES IN PUBLIC EXPENDITURES WITH MULTIPLE SCLEROSIS DRUG TREATMENT IN BRAZIL von Takemoto, M.M.S, Takemoto, M.L, Fernandes, R.A, Duarte, G.G.F, Tolentino, A.C.M, Santos, P.M.L, Moretti, A.I.P

Volltext

PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM von Takemoto, M.M.S, Takemoto, M.L, Fernandes, R.A, Duarte, G.G.F, Moretti, A.I.P, Santos, P.M.L, Tolentino, A.C.M

Volltext

PND58 INPATIENT HEALTH RESOURCE UTILIZATION AMONG MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM von Takemoto, M.M.S, Takemoto, M.L, Fernandes, R.A, Tolentino, A.C.M, Santos, P.M.L, Duarte, G.G.F, Moretti, A.I.P

Volltext

PND7 PREVALENCE OF DRUG-TREATED MULTIPLE SCLEROSIS WITHIN THE BRAZILIAN PUBLIC HEALTHCARE SYSTEM: COMPARATIVE ANALYSIS WITH PUBLISHED PREVALENCE RATES von Takemoto, M.L, Takemoto, M.M.S, Fernandes, R.A, Duarte, G.G.F, Tolentino, A.C.M, Santos, P.M.L, Moretti, A.I.P

Volltext